Which of the following is NOT a part of the NDA requirements?

The correct choice emphasizes that an advertising strategy for marketing is not part of the New Drug Application (NDA) requirements. The NDA is a comprehensive document that pharmaceutical companies submit to the FDA to seek approval for a new drug.

The NDA specifically focuses on critical information regarding the drug's safety and efficacy, ensuring that there is substantial evidence to support its intended use in the market. This includes detailed results from clinical trials, which demonstrate the drug's safety and effectiveness for the proposed indications. Additionally, the NDA requires a thorough description of the manufacturing process and controls, ensuring that the drug can be produced consistently with appropriate quality standards. It also demands information about components and the composition of the drug, which is crucial to understanding how the drug works and any potential interactions or side effects.

On the contrary, while marketing strategies can influence how a drug is presented to the public, they do not pertain to the safety, efficacy, or manufacturing aspects required by the FDA for the approval process. Therefore, an advertising strategy falls outside the core focus of an NDA, which is why it is the correct answer in this context.